Abstract
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon
Original language | English |
---|---|
Pages (from-to) | 125-129 |
Number of pages | 4 |
Journal | Current Clinical Pharmacology |
Volume | 6 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- ABDF
- Bromo-Dragonfly
- FLY-compounds
- Internet monitoring
- phenethylamines
- designer drugs
- ReDNet project
- research chemicals
- psychoactive drugs